Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 6.34M | $247.0M | 5.43% | +311.0K | 2026-06-30 |
| BlackRock, Inc. | 6.19M | $241.0M | 5.31% | -690.6K | 2026-06-30 |
| State Street Corp | 5.61M | $218.0M | 4.81% | +1.21M | 2026-06-30 |
| Vanguard Capital Management LLC | 5.05M | $197.0M | 4.33% | +41.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4.48M | $174.0M | 3.84% | +20.0K | 2026-06-30 |
| Two Sigma Investments, LP | 3.94M | $153.0M | 3.38% | -- | 2026-06-30 |
| Morgan Stanley | 3.49M | $135.0M | 2.99% | +472.1K | 2026-06-30 |
| Citadel Advisors LLC | 2.68M | $104.0M | 2.29% | +61.7K | 2026-06-30 |
| Ameriprise Financial Inc | 2.16M | $84.0M | 1.85% | +477.3K | 2026-06-30 |
| Geode Capital Management, LLC | 2.10M | $81.0M | 1.80% | +15.9K | 2026-06-30 |
